Health assessment tool for cognitive health and brain management.
BrainCheck provides a digital platform for cognitive assessment and care planning, integrating seamlessly into clinical workflows. It features an FDA-cleared Class II digital cognitive assessment, BrainCheck Assess, alongside additional screening tools. The platform objectively measures cognitive function, assisting clinicians in detecting early signs of dementia-related impairment.
Co-founded by Yael Katz, BrainCheck originated from the insight into a significant cognitive care gap. Observing a high prevalence of impairment contrasted with low formal diagnosis rates, impeding timely intervention, the company established an accessible, efficient digital solution for sophisticated cognitive testing.
The platform primarily serves medical professionals, including neurologists, psychiatrists, and primary care providers, enabling objective cognitive evaluation in routine care. BrainCheck’s vision is to close the cognitive care gap by supporting the full continuum of care, from initial assessment to personalized planning, enhancing patient outcomes.
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital | — |
This company has completed 10 funding rounds. Current round is highlighted.
Total Raised
$83.5M
Top Valuation
-
BrainCheck raised $13M in a Early Stage Venture round.
The round was led by Next Coast Ventures.
BrainCheck is a digital health technology company that builds rapid, mobile cognitive assessment and decision support tools for healthcare providers. Its platform enables physicians to screen, assess, and monitor cognitive health efficiently, helping patients live safer, better lives at home while reducing caregiver burden and healthcare costs[1][3][4]. BrainCheck serves healthcare organizations, including over 100 healthcare and athletic institutions, and more than 40,000 individuals use its tools to track cognitive function and share results with their doctors[1]. The company addresses the critical problem of early detection and management of cognitive impairment, a growing public health concern, by providing a fully digital, FDA-registered Class II medical device solution that integrates into clinical workflows[1][4]. BrainCheck has demonstrated strong growth momentum, supported by multiple funding rounds totaling over $39 million and recognition such as the Care Management Innovation Award in 2024[2].
BrainCheck was founded in 2015 by Dr. Yael Katz, a neuroscientist with expertise in computational neuroscience and data analytics, who combined her scientific background and entrepreneurial experience to create a scalable solution for personalized cognitive healthcare[1]. The idea emerged from her desire to leverage her unique skills to solve a pressing healthcare challenge—enabling physicians to deliver high-quality, person-centered cognitive care at scale[1]. Early traction came from rigorous research spanning over 20 years and adoption by healthcare providers seeking efficient cognitive assessment tools[1].
BrainCheck rides the rising trend of digital health innovation focused on cognitive care, a field gaining urgency due to the increasing prevalence of cognitive impairments such as mild cognitive impairment and dementia. The timing is critical as healthcare systems seek scalable, cost-effective solutions to address cognitive decline early, improving outcomes and reducing long-term costs[1][4]. BrainCheck’s technology aligns with broader market forces emphasizing telehealth, personalized medicine, and data-driven clinical decision support. By enabling routine cognitive screening and monitoring, BrainCheck helps close the gap between cognitive impairment prevalence and diagnosis, influencing the ecosystem toward proactive brain health management[3][4].
Looking ahead, BrainCheck is positioned to expand its impact by deepening integration with healthcare providers and broadening its user base, potentially incorporating advanced analytics and AI to enhance predictive capabilities. Trends such as aging populations, increased awareness of brain health, and healthcare digitization will shape its trajectory. BrainCheck’s influence may evolve from a cognitive assessment tool to a comprehensive brain health platform, driving earlier interventions and personalized care pathways. Its mission to make cognitive health a routine part of wellness visits could transform standards of care and patient outcomes in neurology and primary care[3][4].
In summary, BrainCheck leverages cutting-edge neuroscience and technology to empower providers and patients with accessible, validated cognitive health tools, addressing a critical healthcare need with growing urgency and market demand.